Skip to main content
Premium Trial:

Request an Annual Quote

Co-Diagnostics Receives PCR Technology from DNA Logix

NEW YORK (GenomeWeb News) – Co-Diagnostics said recently that certain real-time PCR technology has been transferred to the company from DNA Logix.

DNA Logix transferred four patents and applications pursuant to a purchase agreement between the two firms. Under the terms of the agreement, Co-Diagnostics, based in Salt Lake City, exercised its option to purchase the technology related to real-time PCR diagnostics testing.

The patents and applications that were transferred are titled, "Methods of Preventing Non-Specific Reactions of Nucleotide Sequences;" "Rapid Oligo Probes;" "Detection Primers for Nucleic Acid Extensions or Amplification Reactions;" and "Primers for Nucleic Acid Extension or Amplification Reactions."

In a statement, Co-Diagnostics President Dwight Egan said that "the patents transferred contain cutting-edge technology in the molecular diagnostic testing industry and represent a breakthrough that will enable testing to be performed much less expensively than is standard in the industry at the present time."

The Scan

Omicron's Emergence

The World Health Organization has called Omicron a SARS-CoV-2 "variant of concern," the Los Angeles Times writes.

Not as Much

Merck's pill to treat COVID-19 reduces the risk of hospitalization and death among COVID-19 patients by less than previously reported, the New York Times says.

Bats That Hang Together

Discover magazine writes that researchers have found a social microbiome among vampire bats.

PLOS Papers on CEWAS, Simian Varicella Virus Transcriptome, Dermatomyositis Markers

In PLOS this week: multi-omic approach to home in on genetic risk variants, transcriptomic analysis of the simian varicella virus, and more.